BioClinica, Inc. has established a strategic partnership with Symbiance Inc., a specialty CRO based in Princeton, NJ. Symbiance focuses on oncology and CNS therapeutics and includes a clinical data management unit, biostatistical analysis, and SAS programming divisions supporting Phase I through IV clinical trials.

“With their therapeutic expertise and knowledge of the clinical trial space, Symbiance is an excellent partner for BioClinica’s offerings. I am confident in the added value this partnership will bring to our mutual clients,” said Peter Benton, president of eClinical Solutions for BioClinica.

“The BioClinica Certified Partner Program saw significant growth in 2010,” he continued. “This growth has continued into the new year with the addition of experienced partners like Symbiance, allowing BioClinica to offer both a best in class product suite and added-value services for our clients. As many CROs seek partners that offer the highest level of technical expertise with global reach and support, they are finding that BioClinica fulfills their needs with the flexibility and capabilities that they require.”